Ron DePinho: A Transformative Insight into Lupus – and the Virus Nearly All of Us Carry
Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on LinkedIn:
”A transformative insight into lupus—and a virus nearly all of us carry.
Science Translational Medicine reports that every single case of lupus is triggered by EBV, a virus that silently resides in about 95% of the global population.
If validated, this finding could fundamentally shift our understanding of autoimmunity and the origins of complex diseases like lupus. EBV, long associated with mononucleosis and certain cancers, may also be the hidden instigator behind one of the most enigmatic autoimmune conditions—one that disproportionately affects women and people of color.
- Could EBV biomarkers help us identify lupus earlier or more precisely?
- Would a future EBV vaccine reduce the incidence of lupus and perhaps other autoimmune diseases?
- Can we design targeted therapies that interrupt the EBV–autoimmunity axis?
As we uncover the viral roots of chronic disease, the lines between infectious disease, immunology, and chronic illness are beginning to blur. The implications for public health, biopharma R and D, and vaccine strategy are immense.
One virus. One breakthrough. A whole new way of thinking.”
Stay informed with Hemostasis Today.
-
Jul 4, 2026, 13:53Azusa Nagao: Why Is von Willebrand Disease Still Being Missed in Japan?
-
Jul 4, 2026, 13:32Jim Hoffman: Lupus Treatment Must Balance Disease Control with Long-Term Safety
-
Jul 4, 2026, 13:16Jim Vadolas: New Evidence Linking Iron Dysregulation to Inflammation in Myelodysplastic Syndromes
-
Jul 4, 2026, 12:47Panagiota Tsiatsiou: Tissue Factor Biomarkers Reveal Persistent Procoagulant Activity During Combined Androgen Blockade in Prostate Cancer
-
Jul 4, 2026, 12:45Seema Dawood: Abnormal Nuclear Morphology of Neutrophil
-
Jul 4, 2026, 12:34Omar Adwan: Are You Following Proper Phlebotomy Technique?
-
Jul 4, 2026, 12:24Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
-
Jul 4, 2026, 12:04Lara Bloom: Building Momentum for Rare Diseases
-
Jul 4, 2026, 11:52Heghine Khachatryan: A Valuable Educational Resource on Inhibitor Development